Literature DB >> 22052393

[Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].

Fernando Saldías1, Orlando Díaz.   

Abstract

UNLABELLED: Streptococcus pneumoniae is the main cause of community-acquired pneumonia (CAP) in adults.
OBJECTIVES: To compare accuracy and discriminatory power of three validated rules for predicting clinically relevant adverse outcomes in patients hospitalized with community-acquired pneumococcal pneumonia. MEASUREMENTS: We prospectively compared the pneumonia severity index (PSI), British Thoracic Society score (CURB-65) and severe CAP score (SCAP) in a cohort of 151 consecutive immunocompetent adult patients hospitalized with pneumococcal pneumonia. Major adverse outcomes were admission to ICU, need for mechanical ventilation, in-hospital complications and 30-day mortality. Mean hospital length of stay (LOS) was also evaluated. The predictive indexes were compared based on sensitivity, specificity, and area under the curve of the receiver operating characteristic.
RESULTS: The mean age of 151 immunocompetent adult patients hospitalized with pneumococcal pneumonia was 64 years (range, 16 to 92); 58% were male, 75% had comorbidities, 26% were admitted to the intensive care unit and 9% needed mechanical ventilation. The rate of all adverse outcomes and hospital LOS increased directly with increasing PSI, CURB-65 and SCAP scores. The three severity scores allowed us to predict the risk of in-hospital complications and 30-day mortality. The PSI score was more sensitive and the SCAP was more specific to predict in-hospital complications and the risk of death. However, the SCAP was more sensitive and specific in predicting the use of mechanical ventilation.
CONCLUSION: The severity scores validated in the literature allow us to predict the risk of complications and death in adult patients hospitalized with pneumococcal pneumonia. Nevertheless, the clinical indexes differ in their sensitivity, specificity and discriminatory power to predict different adverse events.

Entities:  

Mesh:

Year:  2011        PMID: 22052393     DOI: /S0716-10182011000500001

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  3 in total

1.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

2.  Community-acquired pneumonia at the Hospital de Clínicas de Porto Alegre: evaluation of a care protocol.

Authors:  Clei Angelo Mocelin; Rodrigo Pires dos Santos
Journal:  Braz J Infect Dis       Date:  2013-07-02       Impact factor: 3.257

3.  Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile.

Authors:  Alberto Fica; Nicolás Bunster; Felipe Aliaga; Felipe Olivares; Lorena Porte; Stephanie Braun; Jeannette Dabanch; Juan Carlos Hormázabal; Antonio Hernández; María Guacolda Benavides
Journal:  Braz J Infect Dis       Date:  2013-10-10       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.